E14K (p.Glu14Lys) variant of GCK (Hexokinase-4)

E14K (p.Glu14Lys) in GCK (Hexokinase-4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes population frequency data and structural context.

E14K (p.Glu14Lys) variant details